Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Companies 0/25
Result 36,611 decisions over 12 months
Reset filters
Minimum amount ? Share of their own holding ?
What the chief executive holds ?
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
12 Feb 2026
Chief Executive Officer
Bought
62,500
$25.00K
26.6%
12 Feb 2026
Chief Executive Officer
Bought
29,500
$24.84K
37.1%
12 Feb 2026
10% owner indirect
Bought
1,940
$23.32K
0.1%
12 Feb 2026
EVP, CLO and CS
Sold at will
14,120
$23.30K
2.1%
12 Feb 2026
Director indirect
Sold at will 2×
1,662
$21.92K
3.1%
12 Feb 2026
Director
Bought
25,000
$21.24K
29.5%
12 Feb 2026
Principal Accounting Officer
Sold at will
132
$19.38K
3.7%
12 Feb 2026
CFO, SVP FINANCE
Sold at will
2,624
$18.58K
3.7%
12 Feb 2026
Director indirect
Bought 14×
3,430
$15.43K
opened
12 Feb 2026
Director
Bought 5×
3,430
$15.30K
6.0%
12 Feb 2026
10% owner indirect
Bought
7,956
$13.69K
1.3%
12 Feb 2026
Director indirect
Bought
230
$13.06K
9.4%
12 Feb 2026
Director
Bought
1,000
$10.99K
4.6%
12 Feb 2026
CLO and Secretary
Sold at will
3,000
$10.22K
0.8%
12 Feb 2026
Chief Financial Officer
Bought
12,000
$10.10K
4.4%
12 Feb 2026
Chief Medical Officer
Bought
12,132
$10.03K
4.5%
12 Feb 2026
Director
Bought
1,000
$9.67K
1.4%
12 Feb 2026
VP, Product Development
Bought
10,000
$8.30K
9.5%
12 Feb 2026
Director
Bought
396
$7.92K
0.5%
12 Feb 2026
Director
Bought
5,000
$7.45K
50.0%
12 Feb 2026
CEO, CFO
Sold at will
3,896
$6.82K
12.5%
12 Feb 2026
Senior Vice President & CHRO indirect
Sold at will
44
$5.98K
100%
12 Feb 2026
Director
Bought
400
$5.84K
25.0%
12 Feb 2026
Chief Scientific Officer
Sold at will
416
$5.00K
0.3%
12 Feb 2026
10% owner
Bought
1,050
$4.73K
0.0%
12 Feb 2026
10% owner
Bought
457
$4.57K
0.3%
12 Feb 2026
Chief Medical Officer
Sold at will
1,989
$3.48K
13.0%
12 Feb 2026
Chief Financial Officer
Bought
1,500
$2.15K
1.3%
12 Feb 2026
President/Co-Portfolio Manager indirect
Bought 6×
774
$2.11K
0.2%
12 Feb 2026
President/Co-Portfolio Manager
Bought
360
$982.80
0.2%
12 Feb 2026
Head of Pharm Ops and Tech
Bought
3
$585.11
0.0%
12 Feb 2026
Director indirect
Bought
6
$81.00
0.0%
11 Feb 2026
Chairman, President & CEO indirect
Sold at will
3,000,000
$37.26M
100%
11 Feb 2026
President & CEO
Sold at will 7×
150,000
$16.75M
28.5%
11 Feb 2026
10% owner
Sold at will
450,000
$15.92M
1.6%
11 Feb 2026
Executive Vice President
Sold at will 18×
13,151
$12.61M
25.2%
11 Feb 2026
Director by Deputization indirect
Sold at will
425,000
$11.33M
2.6%
11 Feb 2026
Director indirect
Sold at will
425,000
$11.33M
2.6%
11 Feb 2026
Director indirect
Sold at will
425,000
$11.33M
2.6%
11 Feb 2026
Director
Sold at will 9×
18,107
$10.81M
34.6%
11 Feb 2026
10% owner
Sold at will
1,155,382
$10.40M
100%
11 Feb 2026
Chairman of the Board
Sold at will 2×
152,960
$9.89M
4.4%
11 Feb 2026
Group President
Sold at will
12,507
$9.59M
12.8%
11 Feb 2026
10% owner
Sold at will 2×
10,285
$6.09M
1.5%
11 Feb 2026
Chief Operating Officer
Sold at will 4×
5,293
$5.74M
10.3%
11 Feb 2026
EVP & General Counsel
Sold at will
75,000
$4.84M
25.5%
11 Feb 2026
Chief Executive Officer
Sold at will 9×
4,706
$4.69M
9.0%
11 Feb 2026
President & COO
Sold at will 10×
4,664
$4.66M
26.2%
11 Feb 2026
President, Arch Capital Group
Sold at will
47,430
$4.56M
9.9%
Showing 25,251–25,300 of 36,611. ← Newer Page 506 of 733 Older →